TEKMIRA PHARMACEUTICAL CORP. 13G

Company

Arbutus Biopharma Corp

Filed

August 16, 2013

Accession Number

0000905383-13-000003

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →